Healthpeak Properties, Inc. (DOC)
(Delayed Data from NYSE)
$22.46 USD
+0.34 (1.54%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $22.46 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
C Value D Growth F Momentum F VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$22.46 USD
+0.34 (1.54%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $22.46 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
C Value D Growth F Momentum F VGM
Zacks News
Reasons to Add Healthpeak Properties (DOC) to Your Portfolio Now
by Zacks Equity Research
High demand for lab assets and rising senior citizens' healthcare spending benefit Healthpeak Properties (DOC).
BXP Rallies 19.5% in 3 Months: Will It Continue to Rise?
by Zacks Equity Research
BXP's assets in a few select markets, diversified tenant base, strategic expansions and a solid balance sheet position bode well for future growth.
Iron Mountain (IRM) Uses MongoDB for its New InSight DXP
by Zacks Equity Research
To manage physical and digital information, Iron Mountain (IRM) uses MongoDB Atlas as the data platform for its InSight DXP.
Healthpeak (DOC) Upgraded to Buy: Here's What You Should Know
by Zacks Equity Research
Healthpeak (DOC) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
What's in the Cards for Medical Properties (MPW) in Q2 Earnings?
by Zacks Equity Research
While Medical Properties' (MPW) Q2 earnings are likely to have benefited from the favorable healthcare industry trends, high interest rates and exposure to certain troubled operators may have hurt it.
Ventas (VTR) Q2 FFO Beats Estimates on Higher Same-Store NOI
by Zacks Equity Research
Ventas' (VTR) Q2 results reflect occupancy and revenue growth in its same-store senior housing operating portfolio.
SBA Communications' (SBAC) Q2 AFFO Beat, Revenues Fall Y/Y
by Zacks Equity Research
SBA Communications' (SBAC) Q2 results reflect a year-over-year site-leasing revenue growth on healthy leasing activity.
Welltower (WELL) Q2 FFO Beat Estimates, Same Store NOI Rises
by Zacks Equity Research
Welltower's (WELL) Q2 earnings outshine estimates driven by a rise in revenues. SHO portfolio occupancy improves year over year.
Healthpeak's (DOC) Q2 FFO Beat Estimates, Same-Store NOI Up
by Zacks Equity Research
Healthpeak's (DOC) Q2 results outshine estimates on better-than-anticipated revenues. Total merger-combined same-store cash NOI improves year over year. It has revised its 2024 outlook.
Compared to Estimates, Healthpeak (DOC) Q2 Earnings: A Look at Key Metrics
by Zacks Equity Research
While the top- and bottom-line numbers for Healthpeak (DOC) give a sense of how the business performed in the quarter ended June 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Healthpeak (DOC) Q2 FFO and Revenues Top Estimates
by Zacks Equity Research
Healthpeak (DOC) delivered FFO and revenue surprises of 2.27% and 5.29%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
What's in the Cards for Healthpeak (DOC) This Earnings Season?
by Zacks Equity Research
While Healthpeak's (DOC) Q2 earnings are likely to have benefited from the healthy demand for lab real estate assets, high interest expenses raise concern.
Is It Wise to Hold Healthpeak Properties (DOC) Stock Now?
by Zacks Equity Research
High demand for lab assets and rising senior citizens' healthcare spending benefit Healthpeak Properties (DOC). However, competition from peers and higher interest rates are concerns.
These 2 Finance Stocks Could Beat Earnings: Why They Should Be on Your Radar
by Zacks Equity Research
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
Equinix (EQIX) Unveils Dell PowerStore on Equinix Metal Service
by Zacks Equity Research
Equinix (EQIX), with Dell Technologies, announces the availability of Dell PowerStore on Equinix Metal service offering to manage a wide range of high-performance multicloud workloads.
Digital Realty (DLR) to Offer Liquid-to-Chip Cooling Technology
by Zacks Equity Research
Digital Realty (DLR) announces high-density deployment support for liquid-to-chip cooling across its 170 global data centers.
Piedmont (PDM) Announces New Lease at 501 W. Church, Orlando
by Zacks Equity Research
Piedmont's (PDM) securing of a new lease with Travel + Leisure at Downtown, Orlando highlights solid demand for its office buildings.
What's in the Cards for Medical Properties (MPW) in Q1 Earnings?
by Zacks Equity Research
While Medical Properties' (MPW) Q1 earnings are likely to have benefited from the favorable healthcare industry trends, the high interest rate environment may have hurt it.
OUTFRONT Media (OUT) Q1 AFFO Meets Estimates, Revenues Up Y/Y
by Zacks Equity Research
OUTFRONT Media (OUT) Q1 2024 results reflect a rise in billboard revenues. However, higher operating expenses and interest expense pose concerns.
Digital Realty's (DLR) Q1 FFO Beat Estimates, Revenues Lag
by Zacks Equity Research
Digital Realty's (DLR) Q1 FFO per share outshine estimates. However, elevated operating expenses hurt the results to some extent.
Ventas (VTR) Q1 FFO Beats Estimates on Higher Same-Store NOI
by Zacks Equity Research
Ventas' (VTR) Q1 results outshine estimates on better-than-anticipated revenues. The same-store NOI improves year over year on strong performance.
Host Hotels' (HST) Q1 AFFO Beat Estimates, Revenues Up Y/Y
by Zacks Equity Research
Host Hotels (HST) posts better-than-expected Q1 results on higher revenues aided by improvements in group and contract business. It has also raised its 2024 AFFO per share outlook.
Healthpeak's (DOC) Q1 FFO Beat Estimates, Same-Store NOI Up
by Zacks Equity Research
Healthpeak's (DOC) Q1 results outshine estimates on better-than-anticipated revenues. Total merger-combined same-store cash NOI improves year over year. It has revised its 2024 outlook.
Healthpeak (DOC) Q1 FFO and Revenues Surpass Estimates
by Zacks Equity Research
Healthpeak (DOC) delivered FFO and revenue surprises of 2.27% and 9.20%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Alexandria (ARE) Beats Q1 AFFO Estimates, Narrows '24 Guidance
by Zacks Equity Research
Alexandria's (ARE) Q1 results reflect healthy leasing activity and rental rate growth.